{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:53:20Z","timestamp":1792450400159,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jns.2014.10.020","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:46:24Z","timestamp":1413420384000},"page":"23-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Vascular comorbidities in the onset and progression of multiple sclerosis"],"prefix":"10.1016","volume":"347","author":[{"given":"Prudence","family":"Tettey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Steve","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce V.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.F.","family":"van der Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 1","key":"10.1016\/j.jns.2014.10.020_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/112.1.133","article-title":"The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability","volume":"112","author":"Weinshenker","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.jns.2014.10.020_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756285608100325","article-title":"Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment","volume":"2","author":"Haussleiter","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jns.2014.10.020_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/qjmed\/hcr012","article-title":"Factors predisposing to the development of multiple sclerosis","volume":"104","author":"Young","year":"2011","journal-title":"QJM"},{"key":"10.1016\/j.jns.2014.10.020_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(04)00933-0","article-title":"Environmental risk factors in multiple sclerosis aetiology","volume":"3","author":"Marrie","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2014.10.020_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ncl.2010.12.007","article-title":"Individual and joint action of environmental factors and risk of MS","volume":"29","author":"van der Mei","year":"2011","journal-title":"Neurol Clin"},{"issue":"13","key":"10.1016\/j.jns.2014.10.020_bb0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1179\/016164106X98080","article-title":"Multiple sclerosis as a vascular disease","volume":"28","author":"Minagar","year":"2006","journal-title":"Neurol Res"},{"issue":"1","key":"10.1016\/j.jns.2014.10.020_bb0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1871527311312010016","article-title":"The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients","volume":"12","author":"Sternberg","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.jns.2014.10.020_bb0045","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s004150050407","article-title":"Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance","volume":"246","author":"Flachenecker","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2014.10.020_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1352458508096680","article-title":"High frequency of adverse health behaviors in multiple sclerosis","volume":"15","author":"Marrie","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2014.10.020_bb0055","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0003-9993(03)00466-0","article-title":"Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis","volume":"84","author":"Slawta","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jns.2014.10.020_bb0060","doi-asserted-by":"crossref","first-page":"868256","DOI":"10.1155\/2012\/868256","article-title":"Weight status in persons with multiple sclerosis: implications for mobility outcomes","volume":"2012","author":"Pilutti","year":"2012","journal-title":"J Obes"},{"issue":"3","key":"10.1016\/j.jns.2014.10.020_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.msard.2012.02.004","article-title":"Weight status and disability in multiple sclerosis: an examination of bi-directional associations over a 24-month period","volume":"1","author":"Pilutti","year":"2012","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jns.2014.10.020_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-0404.2010.01436.x","article-title":"Association between comorbidity and clinical characteristics of MS","volume":"124","author":"Marrie","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.jns.2014.10.020_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PHM.0b013e318194f8b5","article-title":"The prevalence of overweight and obesity in veterans with multiple sclerosis","volume":"88","author":"Khurana","year":"2009","journal-title":"Am J Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.jns.2014.10.020_bb0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jocd.2011.04.012","article-title":"Body composition in ambulatory patients with multiple sclerosis","volume":"14","author":"Sioka","year":"2011","journal-title":"J Clin Densitom"},{"issue":"8","key":"10.1016\/j.jns.2014.10.020_bb0085","doi-asserted-by":"crossref","first-page":"e43675","DOI":"10.1371\/journal.pone.0043675","article-title":"Is metabolic flexibility altered in multiple sclerosis patients?","volume":"7","author":"M\u00e4hler","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jns.2014.10.020_bb0090","first-page":"43","article-title":"Body fat distribution and plasma lipid profiles of patients with multiple sclerosis","volume":"34","author":"\u00c7omo\u011flu","year":"2004","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.jns.2014.10.020_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000128103","article-title":"Vascular disease among hospitalized multiple sclerosis patients","volume":"30","author":"Allen","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"10","key":"10.1016\/j.jns.2014.10.020_bb0100","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/1352458513483889","article-title":"Childhood body mass index and multiple sclerosis risk: a long-term cohort study","volume":"19","author":"Munger","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2014.10.020_bb0105","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.0b013e31828154f3","article-title":"Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome","volume":"80","author":"Langer-Gould","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0110","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.0b013e3181c0d6e0","article-title":"Body size and risk of MS in two cohorts of US women","volume":"73","author":"Munger","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0115","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1177\/1352458512436596","article-title":"High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women","volume":"18","author":"Hedstrom","year":"2012","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.jns.2014.10.020_bb0120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1017\/S1368980011002989","article-title":"Determinants of vitamin D status in young children: results from the Belgian arm of the IDEFICS (Identification and Prevention of Dietary- and Lifestyle-Induced Health Effects in Children and Infants) Study","volume":"15","author":"Sioen","year":"2012","journal-title":"Public Health Nutr"},{"issue":"1","key":"10.1016\/j.jns.2014.10.020_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2011.04320.x","article-title":"Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study","volume":"77","author":"Daly","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.jns.2014.10.020_bb0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e31820af93d","article-title":"Sun exposure and vitamin D are independent risk factors for CNS demyelination","volume":"76","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0135","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"issue":"7410","key":"10.1016\/j.jns.2014.10.020_bb0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/bmj.327.7410.316","article-title":"Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case\u2013control study","volume":"327","author":"van der Mei","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2014.10.020_bb0145","doi-asserted-by":"crossref","DOI":"10.1177\/1352458514533162","article-title":"An adverse lipid profile is associated with disability and progression in disability, in people with MS","author":"Tettey","year":"2014","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"10.1016\/j.jns.2014.10.020_bb0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jns.2014.02.038","article-title":"Adverse lipid profile is not associated with relapse risk in MS: results from an observational cohort study","volume":"340","author":"Tettey","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2014.10.020_bb0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF03405254","article-title":"Validity of self-report screening for overweight and obesity. Evidence from the Canadian Community Health Survey","volume":"99","author":"Elgar","year":"2008","journal-title":"Can J Public Health"},{"key":"10.1016\/j.jns.2014.10.020_bb0160","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/VHRM.S2928","article-title":"Frequency of secondary dyslipidemia in obese children","volume":"4","author":"Korsten-Reck","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jns.2014.10.020_bb0165","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jns.2014.10.020_bb0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2011.07.024","article-title":"Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis","volume":"311","author":"Weinstock-Guttman","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2014.10.020_bb0175","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp-2012-304740","article-title":"Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event","volume":"84","author":"Weinstock-Guttman","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2014.10.020_bb0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0960-0760(95)00106-A","article-title":"Immunomodulatory actions of 1,25-dihydroxyvitamin D3","volume":"53","author":"Lemire","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jns.2014.10.020_bb0185","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1373\/clinchem.2010.144014","article-title":"Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome","volume":"56","author":"Sathyapalan","year":"2010","journal-title":"Clin Chem"},{"issue":"11","key":"10.1016\/j.jns.2014.10.020_bb0190","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","article-title":"Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects","volume":"1","author":"Maffei","year":"1995","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jns.2014.10.020_bb0195","first-page":"4196","article-title":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo","volume":"82","author":"Mohamed-Ali","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jns.2014.10.020_bb0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2007.01.011","article-title":"A key role of leptin in the control of regulatory T cell proliferation","volume":"26","author":"De Rosa","year":"2007","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.jns.2014.10.020_bb0205","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1073\/pnas.0408995102","article-title":"Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells","volume":"102","author":"Matarese","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2014.10.020_bb0210","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jns.2014.10.020_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jns.2014.10.020_bb0220","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2337\/dc06-0811","article-title":"Prevalence of diabetes in patients with multiple sclerosis","volume":"29","author":"Hussein","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2014.10.020_bb0225","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1468-1331.2010.02971.x","article-title":"Comorbidities amongst patients with multiple sclerosis: a population-based controlled study","volume":"17","author":"Kang","year":"2010","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.jns.2014.10.020_bb0230","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/1352458512437814","article-title":"Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia","volume":"18","author":"Marrie","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2014.10.020_bb0235","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0895-4356(94)90099-X","article-title":"Patterns of comorbidity in elderly patients with multiple sclerosis","volume":"47","author":"Fleming","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jns.2014.10.020_bb0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1755-5922.12049","article-title":"Disease modifying therapies modulate cardiovascular risk factors in patients with multiple sclerosis","volume":"32","author":"Sternberg","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jns.2014.10.020_bb0245","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1177\/1352458511414041","article-title":"Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis","volume":"17","author":"Marrie","year":"2011","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.jns.2014.10.020_bb0250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(13)70046-9","article-title":"Diabetes and risk of physical disability in adults: a systematic review and meta-analysis","volume":"1","author":"Wong","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2014.10.020_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/dmrr.2239","article-title":"Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy","volume":"28","author":"Tesfaye","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jns.2014.10.020_bb0260","first-page":"E55","article-title":"Chronic diseases in male veterans with multiple sclerosis","volume":"9","author":"Lavela","year":"2012","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.jns.2014.10.020_bb0265","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10286-005-0274-7","article-title":"Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients","volume":"15","author":"Sanya","year":"2005","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jns.2014.10.020_bb0270","doi-asserted-by":"crossref","DOI":"10.1177\/1352458513475833","article-title":"High risk of cardiovascular diseases after diagnosis of multiple sclerosis","author":"Jadidi","year":"2013","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.jns.2014.10.020_bb0275","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/CIRCULATIONAHA.110.978114","article-title":"Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study","volume":"123","author":"Hajjar","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jns.2014.10.020_bb0280","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1532-5415.2010.03282.x","article-title":"High blood pressure accelerates gait slowing in well-functioning older adults over 18-years of follow-up","volume":"59","author":"Rosano","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"10.1016\/j.jns.2014.10.020_bb0285","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archpsyc.64.10.1180","article-title":"The impact of comorbidity of mental and physical conditions on role disability in the US adult household population","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jns.2014.10.020_bb0290","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1053\/apmr.2002.32817","article-title":"Incidence of functional limitation in older adults: the impact of gender, race, and chronic conditions","volume":"83","author":"Dunlop","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jns.2014.10.020_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002571","article-title":"The effect of multiple chronic conditions on self-rated health, disability and quality of life among the older populations of Northern Ireland and the Republic of Ireland: a comparison of two nationally representative cross-sectional surveys","volume":"3","author":"McDaid","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jns.2014.10.020_bb0300","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0895-4356(00)00363-2","article-title":"Causes and consequences of comorbidity: a review","volume":"54","author":"Gijsen","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jns.2014.10.020_bb0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.65.1.56","article-title":"Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry","volume":"65","author":"Koch-Henriksen","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2014.10.020_bb0310","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/brain\/awh104","article-title":"Trends in survival and cause of death in Danish patients with multiple sclerosis","volume":"127","author":"Bronnum-Hansen","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jns.2014.10.020_bb0315","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jnnp.2007.127332","article-title":"Survival and cause of death in multiple sclerosis: a prospective population-based study","volume":"79","author":"Hirst","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2014.10.020_bb0320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000320245","article-title":"Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study","volume":"35","author":"Christiansen","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.jns.2014.10.020_bb0325","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.msard.2013.03.001","article-title":"Prevalence and incidence of ischemic heart disease in multiple sclerosis: a population-based validation study","volume":"2","author":"Marrie","year":"2013","journal-title":"Mult Scler Relat Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2014.10.020_bb0330","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.clineuro.2013.09.026","article-title":"Autonomic dysfunction in multiple sclerosis","volume":"115","author":"Adamec","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jns.2014.10.020_bb0335","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.clinph.2004.01.012","article-title":"Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS","volume":"115","author":"Saari","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jns.2014.10.020_bb0340","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jns.2014.10.020_bb0345","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1517\/14740338.5.2.265","article-title":"The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?","volume":"5","author":"Murray","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jns.2014.10.020_bb0350","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0355","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/01.wnl.0000257815.20548.df","article-title":"Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study","volume":"68","author":"Jefferson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pathophys.2010.04.002","article-title":"Multiple sclerosis and cerebral endothelial dysfunction: mechanisms","volume":"18","author":"Alexander","year":"2011","journal-title":"Pathophysiology"},{"key":"10.1016\/j.jns.2014.10.020_bb0365","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.01.018","article-title":"Gray matter pathology in (chronic) MS: modern views on an early observation","volume":"282","author":"Geurts","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2014.10.020_bb0370","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood\u2013brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2014.10.020_bb0375","doi-asserted-by":"crossref","first-page":"292598","DOI":"10.1155\/2012\/292598","article-title":"Cholesterol: its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol"},{"key":"10.1016\/j.jns.2014.10.020_bb0380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1073858410373835","article-title":"Cholesterol: a novel regulatory role in myelin formation","volume":"17","author":"Saher","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jns.2014.10.020_bb0385","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2004.02373.x","article-title":"Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood\u2013brain barrier model","volume":"89","author":"Balazs","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2014.10.020_bb0390","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0005-2760(94)00232-N","article-title":"Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid","volume":"1255","author":"Borghini","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jns.2014.10.020_bb0395","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2990.1994.tb01174.x","article-title":"Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis","volume":"20","author":"Newcombe","year":"1994","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.jns.2014.10.020_bb0400","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00018-011-0857-5","article-title":"Regulation of cholesterol homeostasis","volume":"69","author":"Goedeke","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jns.2014.10.020_bb0405","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","article-title":"Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation","volume":"39","author":"Bjorkhem","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jns.2014.10.020_bb0410","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","article-title":"Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation","volume":"93","author":"Lutjohann","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2014.10.020_bb0415","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1367-5931(99)00073-3","article-title":"Metals and neuroscience","volume":"4","author":"Bush","year":"2000","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jns.2014.10.020_bb0420","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1028415031000115945","article-title":"Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis","volume":"6","author":"Besler","year":"2003","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.jns.2014.10.020_bb0425","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/ars.2009.2668","article-title":"Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities","volume":"12","author":"Adibhatla","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jns.2014.10.020_bb0430","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/17460875.2.4.403","article-title":"Role of lipids in brain injury and diseases","volume":"2","author":"Adibhatla","year":"2007","journal-title":"Futur Lipidol"},{"key":"10.1016\/j.jns.2014.10.020_bb0435","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/138161211795049831","article-title":"Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease","volume":"17","author":"Tsimikas","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jns.2014.10.020_bb0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0404.2002.01334.x","article-title":"Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis","volume":"106","author":"Giubilei","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2014.10.020_bb0445","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1352458508098371","article-title":"Paraoxonase 1 activity in different types of multiple sclerosis","volume":"15","author":"Jamroz-Wisniewska","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2014.10.020_bb0450","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1155\/2013\/567162","article-title":"New markers of early cardiovascular risk in multiple sclerosis patients: oxidized-LDL correlates with clinical staging","volume":"34","author":"Palavra","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.jns.2014.10.020_bb0455","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-511X-9-19","article-title":"Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients","volume":"9","author":"Salemi","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jns.2014.10.020_bb0460","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-8-127","article-title":"Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis","volume":"8","author":"Weinstock-Guttman","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jns.2014.10.020_bb0465","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2012-304740","article-title":"Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event","author":"Weinstock-Guttman","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2014.10.020_bb0470","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2146\/ajhp110675","article-title":"Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis","volume":"69","author":"Bhardwaj","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jns.2014.10.020_bb0475","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(04)16205-3","article-title":"Oral simvastatin treatment in relapsing\u2013remitting multiple sclerosis","volume":"363","author":"Vollmer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2014.10.020_bb0480","doi-asserted-by":"crossref","first-page":"PL02.001","DOI":"10.1212\/WNL.80.7_supplement.PL02.001","article-title":"THE MS-STAT TRIAL: high dose simvastatin slows brain atrophy and delays disability in secondary progressive multiple sclerosis: a Phase II placebo-controlled trial [abstract]","volume":"80","author":"Chataway","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0485","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1352458509358909","article-title":"Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing\u2013remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy","volume":"16","author":"Lanzillo","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2014.10.020_bb0490","doi-asserted-by":"crossref","first-page":"e1928","DOI":"10.1371\/journal.pone.0001928","article-title":"Oral high-dose atorvastatin treatment in relapsing\u2013remitting multiple sclerosis","volume":"3","author":"Paul","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jns.2014.10.020_bb0495","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/1352458510369147","article-title":"Simvastatin treatment in patients with relapsing\u2013remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial","volume":"16","author":"Togha","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2014.10.020_bb0500","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1212\/WNL.0b013e3181a92b96","article-title":"Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a","volume":"72","author":"Rudick","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0505","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S1474-4422(11)70144-2","article-title":"Simvastatin as add-on therapy to interferon beta-1a for relapsing\u2013remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial","volume":"10","author":"Sorensen","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2014.10.020_bb0510","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1212\/WNL.0b013e31824f7fdd","article-title":"Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study","volume":"78","author":"Waubant","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.10.020_bb0515","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00415-012-6513-7","article-title":"Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial","volume":"259","author":"Kamm","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2014.10.020_bb0520","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/01.wnl.0000319698.40024.1c","article-title":"Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis","volume":"71","author":"Birnbaum","year":"2008","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1400673X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1400673X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T23:26:59Z","timestamp":1717457219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1400673X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":104,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0022510X1400673X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.10.020","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular comorbidities in the onset and progression of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}